For the fourth year in a row, Gowling WLG has been recognized for its unparalleled expertise in the life sciences industry, taking home three awards at the 2016 LMG Life Sciences Awards ceremony last night in New York.
The firm received top honours for:
- Canadian Patent Non-Contentious Firm of the Year
- Canadian Financial & Transactional Attorney of the Year
- Canadian Patent Non-Contentious Attorney of the Year
As Canadian Patent Non-Contentious Firm of the Year, Gowling WLG was recognized for its in-depth life sciences expertise and history of successfully protecting and enforcing intellectual property rights for clients across Canada and around the world.
Firm partner Paul Armitage was named Canadian Financial & Transactional Attorney of the Year. Based in Vancouver, Armitage has extensive experience with life sciences collaborations and licensing, representing clients on their global intellectual property-intensive transactions and academic partnerships. He also works extensively in the field of information technology, commercial transactions and privacy advisory work.
Jay Zakaïb was awarded Canadian Patent Non-Contentious Attorney of the Year. An Ottawa-based partner, Zakaïb advises clients on managing patent portfolios (during prosecution and post grant) as well as regulatory requirements to secure appropriate product protection through patent enforcement, regulatory strategies and, where available, data protection. While recognized for the non-contentious side of his practice, Zakaïb has also successfully litigated numerous patent and trademark disputes for his clients.
Introduced in 2013, the LMG Life Sciences Awards celebrate the achievements of the leading life sciences law firms and practitioners in Canada, the U.S. and Europe. The firm was represented at this year’s awards ceremony by Paul Armitage.
With over 150 professionals across Canada and around the world, Gowling WLG’s Life Sciences Group delivers top-tier services to a broad spectrum of clients — from investors and public issuers to innovative startups and multinational brands — in a range of key life sciences industries, including pharmaceuticals, biotechnology, medical devices, diagnostics, healthcare services, vaccines, food and beverage, agriculture and cosmetics.